Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Schell

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Journal of Infection|December 12, 2003
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patientsW J Steinbach, W A Schell, J L Miller, et al.
AIDS (London, England)|March 1, 1996
Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapyA E Heald, G M Cox, W A Schell, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
In vitro and in vivo efficacy of the triazole TAK-187 against Cryptococcus neoformansW A Schell, G M De Almeida, R K Dodge, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1M L Cameron, W A Schell, S Bruch, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2016
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong <i>In Vitro</i> Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal CompoundsW A Schell, A M Jones, E P Garvey, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 31, 2007
Caspofungin for the treatment of azole resistant candidemia in a premature infantP B Smith, W J Steinbach, C M Cotten, et al.
Journal of Medicinal Chemistry|May 18, 2001
Diguanidino and "reversed" diamidino 2,5-diarylfurans as antimicrobial agentsC E Stephens, F Tanious, S Kim, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformansJ L Miller, W A Schell, E A Wills, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
In vitro antifungal activities of a series of dication-substituted carbazoles, furans, and benzimidazolesM Del Poeta, W A Schell, C C Dykstra, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agentsM Del Poeta, W A Schell, C C Dykstra, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Infection|December 12, 2003
Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patientsW J Steinbach, W A Schell, J L Miller, et al.
AIDS (London, England)|March 1, 1996
Oropharyngeal yeast flora and fluconazole resistance in HIV-infected patients receiving long-term continuous versus intermittent fluconazole therapyA E Heald, G M Cox, W A Schell, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
In vitro and in vivo efficacy of the triazole TAK-187 against Cryptococcus neoformansW A Schell, G M De Almeida, R K Dodge, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1M L Cameron, W A Schell, S Bruch, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2016
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong <i>In Vitro</i> Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal CompoundsW A Schell, A M Jones, E P Garvey, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|January 31, 2007
Caspofungin for the treatment of azole resistant candidemia in a premature infantP B Smith, W J Steinbach, C M Cotten, et al.
Journal of Medicinal Chemistry|May 18, 2001
Diguanidino and "reversed" diamidino 2,5-diarylfurans as antimicrobial agentsC E Stephens, F Tanious, S Kim, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformansJ L Miller, W A Schell, E A Wills, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
In vitro antifungal activities of a series of dication-substituted carbazoles, furans, and benzimidazolesM Del Poeta, W A Schell, C C Dykstra, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1998
Structure-in vitro activity relationships of pentamidine analogues and dication-substituted bis-benzimidazoles as new antifungal agentsM Del Poeta, W A Schell, C C Dykstra, et al.
Pageof 4